Jacques Galipeau

Jacques Galipeau is a prominent figure in the field of cell and gene therapy, with extensive experience in academic medicine and biopharmaceutical leadership. Here's an overview of his professional background and current roles:

Current Positions

Associate Dean for Therapeutics Development: Dr. Galipeau currently serves as the Associate Dean for Therapeutics Development at the University of Wisconsin-Madison School of Medicine and Public Health, a position he has held since September 2018.1 In this role, he focuses on:

• Identifying collaborative opportunities
• Assembling cross-disciplinary teams for innovation and discovery in cell technologies and therapeutics
• Establishing partnerships within the Wisconsin biotechnology and life sciences ecosystem

ISCT Leadership: At the International Society for Cell & Gene Therapy (ISCT), Dr. Galipeau has held several leadership positions:

• Immediate Past President & Chair, Strategic Advisory Council (current)
• President (May 2022 - recent past)1
• President-Elect (June 2020 - May 2022)1

Professional Background

Dr. Galipeau's career includes:

• Director of the Program for Advanced Cell Therapy (PACT) at the University of Wisconsin-Madison
• Professor of Hematology and Oncology and Director of the Emory Personalized Immunotherapy Center at Emory University in Atlanta, Georgia3
• Associate Professor of Medicine and Oncology at McGill University (June 2004 - October 2009)1

Expertise and Focus

Dr. Galipeau is known for his work in:

• Cell and gene therapy innovations
• Translational research in cellular therapies
• Academic health center biopharmaceutical development
• Advancing early clinical phase development of cell therapies2

His leadership at ISCT has emphasized:

• Providing a voice for the unique challenges and opportunities in the Cell & Gene Therapy field
• Focusing on education and workforce training
• Supporting the growth and impact of the society journal, Cytotherapy
• Shaping the cell therapy ecosystem to improve human health outcomes1

Dr. Galipeau's work spans academic research, clinical translation, and industry collaboration, making him a key figure in advancing cell and gene therapies from laboratory discoveries to patient treatments.